Skip to main content

Advertisement

Log in

Novel MTMR2 mutation causing severe Charcot-Marie-Tooth type 4B1 disease: a case report

  • Short Communication
  • Published:
neurogenetics Aims and scope Submit manuscript

Abstract

Mutations in myotubularin-related protein 2 (MTMR2) were shown to underlie Charcot-Marie-Tooth type 4B1 (CMT4B1) disease, a rare autosomal recessive demyelinating neuropathy, characterized by severe early-onset motor and sensory neuropathy. We describe three siblings of consanguineous kindred presenting with hypotonia, reduced muscle tone, action tremor, dysmetria, areflexia, and skeletal deformities, consistent with a diagnosis of CMT. Whole-exome sequencing identified a novel homozygous c.336_337 insertion mutation in MTMR2, resulting in a frameshift and putative truncated protein. In this concise report, we discuss the clinical presentation of this rare disease and support the limited number of observations regarding the pathogenesis of MTMR2-related neuropathies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Hoyle JC, Isfort MC, Roggenbuck J, Arnold WD (2015) The genetics of Charcot–Marie–Tooth disease: current trends and future implications for diagnosis and management. Appl Clin Genet 8:235

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Laurá M, Pipis M, Rossor AM, Reilly MM (2019) Charcot–Marie–Tooth disease and related disorders: an evolving landscape. Curr Opin Neurol 32:641–650

    Article  Google Scholar 

  3. Flusser H, Halperin D, Kadir R, Shorer Z, Shelef I, Birk OS (2018) Novel SBF1 splice-site null mutation broadens the clinical spectrum of Charcot-Marie-Tooth type 4B3 disease. Clin Genet 94:473–479

    Article  CAS  Google Scholar 

  4. Halperin D, Kadir R, Perez Y, Drabkin M, Yogev Y, Wormser O, Berman EM, Eremenko E, Rotblat B, Shorer Z, Gradstein L, Shelef I, Birk R, Abdu U, Flusser H, Birk OS (2019) SEC31A mutation affects ER homeostasis, causing a neurological syndrome. J Med Genet 56:139–148

    Article  CAS  Google Scholar 

  5. Markus B, Alshafee I, Birk OS (2014) Deciphering the fine-structure of tribal admixture in the Bedouin population using genomic data. Heredity (Edinb) 112:182–189

    Article  CAS  Google Scholar 

  6. Laporte J, Bedez F, Bolino A, Mandel J-L (2003) Myotubularins, a large disease-associated family of cooperating catalytically active and inactive phosphoinositides phosphatases. Hum Mol Genet 12:R285–R292

    Article  CAS  Google Scholar 

  7. Raess MA, Friant S, Cowling BS, Laporte J (2017) WANTED–dead or alive: myotubularins, a large disease-associated protein family. Adv Biol Regul 63:49–58

    Article  CAS  Google Scholar 

  8. Hnia K, Vaccari I, Bolino A, Laporte J (2012) Myotubularin phosphoinositide phosphatases: cellular functions and disease pathophysiology. Trends Mol Med 18:317–327

    Article  CAS  Google Scholar 

  9. Pareyson D, Stojkovic T, Reilly MM, Leonard-Louis S, Laurà M, Blake J, Parman Y, Battaloglu E, Tazir M, Bellatache M, Bonello-Palot N, Lévy N, Sacconi S, Guimarães-Costa R, Attarian S, Latour P, Solé G, Megarbane A, Horvath R, Ricci G, Choi BO, Schenone A, Gemelli C, Geroldi A, Sabatelli M, Luigetti M, Santoro L, Manganelli F, Quattrone A, Valentino P, Murakami T, Scherer SS, Dankwa L, Shy ME, Bacon CJ, Herrmann DN, Zambon A, Tramacere I, Pisciotta C, Magri S, Previtali SC, Bolino A (2019) A multicenter retrospective study of Charcot-Marie-Tooth disease type 4B (CMT4B) associated with mutations in myotubularin-related proteins (MTMRs). Ann Neurol 86:55–67

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Vaccari I, Dina G, Tronchere H, et al. (2011) Genetic interaction between MTMR2 and FIG4 phospholipid phosphatases involved in Charcot-MarieTooth neuropathies. PLoS Genet 7:

  11. Murakami T, Kutoku Y, Nishimura H, Hayashi M, Abe A, Hayasaka K, Sunada Y (2013) Mild phenotype of Charcot–Marie–Tooth disease type 4B1. J Neurol Sci 334:176–179

    Article  Google Scholar 

  12. Abdalla-Moady T, Peleg A, Sadeh O, Badarneh K, Fares F (2018) Whole-exome sequencing identifies a novel homozygous frameshift mutation in the MTMR2 gene as a causative mutation in a patient with Charcot-Marie-Tooth disease type 4B1. Mol Neurobiol 55:3546–3550

    Article  CAS  Google Scholar 

  13. Houlden H, King RHM, Wood NW et al (2001) Mutations in the 5′ region of the myotubularin-related protein 2 (MTMR2) gene in autosomal recessive hereditary neuropathy with focally folded myelin. Brain 124:907–915

    Article  CAS  Google Scholar 

  14. Zambon AA, Sora MGN, Cantarella G et al (2017) Vocal cord paralysis in Charcot–Marie–Tooth type 4b1 disease associated with a novel mutation in the myotubularin-related protein 2 gene: a case report and review of the literature. Neuromuscul Disord 27:487–491

    Article  Google Scholar 

  15. Nouioua S, Hamadouche T, Funalot B, Bernard R, Bellatache N, Bouderba R, Grid D, Assami S, Benhassine T, Levy N, Vallat JM, Tazir M (2011) Novel mutations in the PRX and the MTMR2 genes are responsible for unusual Charcot-Marie-Tooth disease phenotypes. Neuromuscul Disord 21:543–550

    Article  Google Scholar 

  16. Scott P, Bruwer Z, Al-Kharusi K et al (2016) Occurrence of optic neuritis and cervical cord schwannoma with Charcot-Marie-Tooth type 4B1 disease. Oman Med J 31:227–230

    Article  Google Scholar 

  17. Verny C, Ravisé N, Leutenegger AL et al (2004) Coincidence of two genetic forms of Charcot–Marie–Tooth disease in a single-family. Neurology 63:1527–1529

    Article  CAS  Google Scholar 

  18. Wang H, Kaçar Bayram A, Sprute R, Ozdemir O, Cooper E, Pergande M, Efthymiou S, Nedic I, Mazaheri N, Stumpfe K, Azizi Malamiri R, Shariati G, Zeighami J, Bayram N, Naghibzadeh SK, Tajik M, Yaşar M, Sami Güven A, Bibi F, Sultan T, Salpietro V, Houlden H, Per H, Galehdari H, Shalbafan B, Jamshidi Y, Cirak S (2019) Genotype-phenotype correlations in Charcot-Marie-Tooth disease due to MTMR2 mutations and implications in membrane trafficking. Front Neurosci 13:974

    Article  Google Scholar 

Download references

Acknowledgments

We thank the families for participating in this study.

Availability of data and materials

The data are available on request from the corresponding author.

Funding

The study was supported by the Legacy Heritage Bio-Medical program of the Israel Science Foundation (grant no. 1798/16), the Morris Kahn Family Foundation, and the National Knowledge Center for Rare / Orphan Diseases sponsored by the Israel Ministry of Science, Technology and Space.

Author information

Authors and Affiliations

Authors

Contributions

Genetic and molecular studies: DH, AS, OW, MD, VD and YY. Clinical characterization: DH and HF. Writing the manuscript: DH, AS, and OSB. OSB initiated and supervised the project. Approved by all authors.

Corresponding author

Correspondence to Ohad S. Birk.

Ethics declarations

Conflict of interest

None.

Ethics approval

Soroka Medical Center IRB.

Patient consent

Obtained.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Halperin, D., Sapir, A., Wormser, O. et al. Novel MTMR2 mutation causing severe Charcot-Marie-Tooth type 4B1 disease: a case report. Neurogenetics 21, 301–304 (2020). https://doi.org/10.1007/s10048-020-00617-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10048-020-00617-2

Keywords

Navigation